Synopsis of recent research by authors named "Yan-Zhang Hao"
- Yan-zhang Hao's recent research primarily focuses on the efficacy and safety of combined-modality therapies in treating various types of cancer, particularly in elderly patients with non-small-cell lung cancer (NSCLC) and gastric cancer, aiming to improve treatment outcomes through innovative approaches.
- The research highlights significant findings such as the role of apelin and its receptor APJ as potential markers for predicting treatment response in gastric cancer patients receiving concurrent chemoradiotherapy with Endostar therapy, indicating a need for personalized treatment strategies.
- A notable study by Hao demonstrated how microRNA-182 affects chemosensitivity to cisplatin in NSCLC by targeting the protein PDCD4, suggesting that understanding microRNA profiles may enhance therapeutic efficacy in lung cancer treatment.